Introduction
============

Pleiotropy, a term first coined in 1910, describes the phenomenon where a single gene has multiple biological functions ([@evw228-B34]; [@evw228-B42]) . Initially, pleiotropy was considered to be rare, as it was thought that most genes only possessed a single function ([@evw228-B34]), and this idea of a single gene, single function remained throughout most of the 20th century ([@evw228-B42]). However, as our understanding of molecular biology has improved, it is becoming evident that pleiotropy is nearly ubiquitous ([@evw228-B42]), and examples were found in diverse fields of biology, ranging from normal development and aging to complex diseases ([@evw228-B40]; [@evw228-B50]). Pleiotropy has been previously classified into seven types ([@evw228-B22]): 1) Artefactual---mutations affect multiple independent genes, 2) Secondary---proteins affect one biochemical process which results in a complex set of phenotypes, 3) Adoptive---proteins having different tissue specific functions, 4) Parsimonious---proteins preforming the same function in multiple pathways, 5) Opportunistic---proteins having one primary function and additional secondary roles, 6) Combinatorial---proteins having different functions depending on which proteins it is interacting with, and 7) Unifying - proteins fulfill multiple roles within a single biological pathway. A well-documented example of pleiotropy (adoptive) has been shown for *αβ-crystallin* that contributes to both cataracts and diffuse cardiomyopathy ([@evw228-B23]; [@evw228-B28]; [@evw228-B47]). Another example (parsimonious) is the *CFTR* gene which results in a range of phenotypes from pancreatic insufficiency and infertility to lung infections ([@evw228-B48]).

It was hypothesized that genes affecting multiple traits would likely experience stronger purifying selection, thus restricting the rate at which they evolve ([@evw228-B6]). Additionally, it was recognized that if multiple phenotypes were affected by a single mutation, not all phenotypic effects would be uniformly beneficial nor uniformly detrimental ([@evw228-B54]). Such possibly antagonistic effects may inform our understanding of the maintenance of disease causing alleles in populations. Many studies have provided evidence for the ability of pleiotropy to constrain gene evolution, using protein--protein interaction (PPI) networks, Gene Ontology terms, and phenotypes of gene knockouts as measurements of pleiotropy ([@evw228-B16], [@evw228-B17]; [@evw228-B24]; [@evw228-B15]; [@evw228-B14]; [@evw228-B21]; [@evw228-B27]; [@evw228-B39]; [@evw228-B3]; [@evw228-B7]). Despite the support for the existence of pleiotropic constraints, prior studies could not, for the most part, explicitly describe the underlying molecular processes that impact the rate of gene evolution and whether domain function directly affected the degree of constraint. Additional models of evolutionary constraints have also been proposed that act independently of pleiotropy ([@evw228-B61]), such as developmental stage ([@evw228-B33]), gene methylation status ([@evw228-B8]), protein synthesis ([@evw228-B58][@evw228-B56]), protein folding ([@evw228-B12]; [@evw228-B58]), contact density ([@evw228-B63]), codon bias ([@evw228-B1]; [@evw228-B35]), and gene expression ([@evw228-B11]; [@evw228-B32]; [@evw228-B19]; [@evw228-B57]) (currently considered the major driver of evolutionary constraint), although these have not been extensively examined in conjunction with possible pleiotropic constraints in multicellular organisms.

In recent years, the generation of high quality, large-scale, and less biased datasets, documenting gene and protein functions, have provided powerful resources to study the molecular mechanisms underlying pleiotropic constraint ([@evw228-B44]). Projects such as ENCODE ([@evw228-B18]; [@evw228-B2]), provide an unparalleled set of functional information on proteins within the human transcription factor (TF) network, including the number of interacting partners that serve as a measurement of pleiotropy. The breadth and quality of these and related data allow us to assess fundamental questions regarding the role of domain function in constraining gene evolution.

In this study, we looked at the number of TF--TF interactions, and the number of DNA binding targets as measures of pleiotropy. Based on the seven types of pleiotropy, these measurements of pleiotropy would primarily qualify as opportunistic, although these data likely include instances of adoptive, combinatorial and unifying pleiotropy. We explored how these two measurements of pleiotropy correlated to the evolutionary rates of the full proteins as well as each class of functional domain separately. More specifically we investigated whether the constraint caused by the two molecular functions differed with respect to how they constrained the protein\'s and/or domain\'s evolutionary rates ([fig. 1A](#evw228-F1){ref-type="fig"}). Additionally, we were interested in how the number of TF-TF interactions and the number of DNA binding targets correlated with the number of protein interacting domains (PIDs) and DNA Binding domains ([fig. 1B](#evw228-F1){ref-type="fig"}). We also assessed whether TFs identified in GWAS are more pleiotropic and more constrained than non-associated TFs. [Fig]{.smallcaps}. 1.---Models of constraint. (*A*) A hypothetical protein containing two domains of different molecular functions (Red or Blue). Brackets illustrate which regions of the protein are constrained, and arrows show the direction of the constraint. Top) the molecular function in question exhibits no constraint on the evolutionary rates of either functional domain class. Bottom) The molecular function in question can exhibit either a constraint on the evolutionary rate of a single class of domains (Restricted Constraint), or constrain both/all classes of domains (Global Constraint). In the case of a global constraint, arrows indicate the direction that the constraint is acting (i.e., the function of the Red domain directly constrains the Red domain and indirectly the Blue domain \[Red → Blue\]). *(B)* Each red circles indicate a protein domain in a single class of functions, the number of lines indicate the number of interactions in which each domain is involved. Each column models what would happen to the number of interactions as the number of domains increases from one to three under three different hypotheses. Left Column) No correlation---the total number of interactions that a protein is involved in does not change as the number of domains increases from one to three, Middle column) Direct correlation---the total number of interactions increases linearly as the number of domains increases from one to three, Right Column) Inverse correlation---the number of interactions decreases as the number of domains increase (increased specificity).

Methods
=======

Human TF Identification and Sequence Retrieval
----------------------------------------------

TFs were identified as previously described ([@evw228-B36]); briefly, any gene that is annotated as a "TF" by the Gene Ontology database or [@evw228-B37], as well as all genes whose Entrez description field contains the word "transcription" was considered a TF. After annotating using these automated processes, the gene list was manually curated to remove any genes that did not belong on a list of TFs, resulting in a final list of 1988 TFs in the human genome ([@evw228-B36]).

In order to calculate the evolutionary rates of the TF proteins and functional domains, we first collected orthologs of each of the 1988 TF genes from NCBI for the following 12 species: *Homo sapiens, Pan paniscus, Macaca mulatta, Pan troglodytes, Nomascus leucogenys, Chlorocebus sabaeus, Tarsius syrichta, Papio anubis, Callithrix jacchus, Otolemur garnettii, Saimiri boliviensis, and Gorilla gorilla.* On average we were able to identify orthologues in 9.3 species per human TF; the average of fewer than 12 orthologous sequences per TF was due to incomplete annotation and sequencing of non-human species. Each coding sequence (CDS) was identified based on the corresponding Genbank file for each gene and was later used for all evolutionary rate calculations for the full proteins as well as their functional domains.

Functional Domain Identification
--------------------------------

To calculate the evolutionary rates of the functional domains, each human TF CDS was translated into its amino acid sequence using the translate function in Biopython package Bio.Seq ([@evw228-B9]). These protein sequences were then run through the NCBI Batch Web CD-Search Tool against the Conserved Domain Database ([@evw228-B29]) to identify all annotated domains in each protein. Based on the domain descriptions from the NCBI CD database, we identified all domains related to either PPIs or DNA binding. These domain sequences were then aligned to the orthlogous protein sequences for all available non-human species, using ClustalOmegaCommandline in the Biopython package ([@evw228-B9]) . This selection process allowed us to accurately define functional domains for species whose genomes are poorly annotated. All PPI domains within a single protein were concatenated to form a single sequence. Similarly, all DNA binding domains (DBD) within a single gene were concatenated. Additionally, we also counted the total number of PPI domains and DNA binding domains found in each gene.

Evolutionary Rate Calculation
-----------------------------

Each set of full length CDS and all sets of orthologous domains were aligned codon by codon using the ClutsalOmegacommandLine ([@evw228-B9]). This alignment was used to create a Maximum Likelihood tree using the RaxML commandline package in Biopython ([@evw228-B41]; [@evw228-B43]). The sequence alignments and phylogenetic trees were then used to calculate the evolutionary rate (dN/dS) using PAML codeml program (seqtype = 1, NSsites = \[0\], CodonFreq = 2, fix_alpha = 1, kappa = 4.54006, model = 0, RateAncestor = 0), which were generated under a neutral evolution model ([@evw228-B31]; [@evw228-B59]; [@evw228-B43]). When either the dN = 0 or the dS = 0 a value of 0.0001 was automatically assigned by the software; these cases were removed from our analyses, as the assigned value does not accurately reflect the evolutionary rate of the protein. The resulting dN/dS scores were used as the evolutionary rate for all analyses in this study.

Number of TF--TF Interactions
-----------------------------

To determine the number of PPIs between 2 TFs (TF--TF interactions) for each TF in our dataset we mined the STRING v9.1 protein interaction database ([@evw228-B13]). Our search was restricted to TF-TF interactions with High-throughput experimental evidence, thereby reducing the bias that might be created for well-studied genes. In total we were able to find 80,155 TF--TF interactions for 1,661 TFs (mean = 70.2 interactions per TF), accounting for 2% of the total interactions in the entire STRING v9.1 database. This yielded the number of TF--TF interactions for each of the 1,661 genes for which the data was available.

Number of DNA-Binding Targets
-----------------------------

The number of DNA-binding targets for each TF was calculated from wgEncodeRegTfbsClusteredV3 database, found at <http://genome.ucsc.edu/cgi-bin/hgTrackUi?db=hg19&g=wgEncodeRegTfbsClusteredV3>. The ENCODE TfbsV3 data set consists of 690 Chip-Seq experiments, encompassing 161 TF and 91 different cell lines, with all TFs having at least 2 replicates. The data collection for all experiments followed the ENCODE Guidelines for Experiments for ChIP-seq experiments ([@evw228-B10]; [@evw228-B18]; [@evw228-B52]).

As part of the Standard Protocol for Encode ChIP-seq experiments, every experiment was subject to two peak calling procedures ([@evw228-B10]), SPP (which determines peaks based on by the Signal Score (\[ChIP signal enrichment\]/\[input DNA signal\])) ([@evw228-B26]), and PeakSeq (which determines peaks based on the expected false discovery rate) ([@evw228-B38]). Data shown is from the SPP peak calls, which were shown to be consistent for peak calling ([@evw228-B62]). This yielded the number of DNA binding targets for each of the 161 genes for which the data were available.

GWAS Association
----------------

In order to determine which genes were associated with disease phenotypes, we mined the NHGRI GWAS catalog NHGRI GWAS catalog ([@evw228-B53]). All TF genes associated with SNPs that reached genome wide significance (*P*-value \< 10^−8^) in at least 1 GWAS were recorded as being a GWAS associated TF, all other TF genes were recorded as not being GWAS associated.

Statistics
----------

In total, we calculated eight variables for each of the 1,988 TF encoding gene (no. of TF--TF interactions, no. of DNA binding targets, dN/dS of full TF, dN/dS of PPI domains, dN/dS of DNA binding domains, no. of PPI domains, no. of DNA binding domains, and GWAS association). We tested for correlation among the variables as shown in [supplemental table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1) online. The dN/dS measurements, no. of TF--TF interactions and no. of DNA-binding targets were natural log transformed in all analyses in this study. Correlation and significance (*P*-value) between all sets of continuous data were performed using the linear model package in R. Correlations including either the no. of PID or no. of DBD were calculated using Spearman Rank Correlation, all other correlations were calculated using Pearson correlation. Students *t*-test was used to test differences between GWAS and non-GWAS groups of TFs in regard to the no. of TF--TF interactions, DNA-binding targets, or dN/dS values. Heterogeneity among correlations was calculated based on a one-tailed Fisher r-to-z transformation to assess the significance of the differences between two correlations.

Results
=======

Evolutionary Rates of Complete TF Coding Regions
------------------------------------------------

In general, we found that increasing pleiotropy in TFs did constrain gene evolution as TFs with more interactions had a lower evolutionary rates regardless of the molecular function. The evolutionary rates of the TFs (as assessed by dN/dS) were negatively correlated with both the number of TF--TF interactions (Pearson *r* = −0.310, *P*-value = 5e-36; [fig. 2A](#evw228-F2){ref-type="fig"}) and the number of DNA-binding targets (Pearson *r* = −0.199, *P*-value = 0.014; [fig. 2B](#evw228-F2){ref-type="fig"}). However, the correlation of dN/dS with TF-TF interactions were not significantly stronger than the correlation with the DNA binding targets (*P*-value = 0.0823). Additionally, we saw a significant positive correlation between the numbers of TF--TF interactions and the DNA binding targets (Pearson *r* = 0.337, *P*-value = 2e-05; [fig. 2C](#evw228-F2){ref-type="fig"}). Therefore, it is clear that having more TF--TF interactions and DNA binding targets is associated with slower gene evolution, but the effect size varies with domain function. [Fig]{.smallcaps}. 2.---Pleiotropic constraints on protein evolutionary rate. X-axes represent the log transformed number of either DNA-binding targets or TF--TF interactions sand the Y axes are the log transformed evolutionary rates as measured by dN/dS for A and B. *(A)* The ln(evolutionary rate of the full TF) plotted against the ln(TF--TF interactions), *n* = 1,552. *(B)* The ln(evolutionary rate of the full TF) plotted against the ln(DNA-binding targets), *n* = 152. *(C)* The correlation between the log transformed number of TF--TF interactions and the log transformed number of DNA-binding targets, *n* = 154. dN/dS = evolutionary rate, TF--TF = no. of TF--TF interactions, DNA binding targets = no. of TF--DNA interactions.

Evolutionary Rates of TF Protein Domains
----------------------------------------

The number of TF--TF interactions affected the evolution of both PPI and DNA binding domains. In contrast, the number of DNA-binding targets per TF only affected the evolution of the DNA binding domains ([fig. 2](#evw228-F2){ref-type="fig"}). The evolutionary rates of both the PPI and DNA-binding domains were negatively correlated with the number of TF--TF interactions (Pearson *r* = −0.191, *P*-value = 9e-7; [fig. 3A](#evw228-F3){ref-type="fig"}, and *P*-value = 6e-06; [fig. 3B](#evw228-F3){ref-type="fig"}, respectively). The number of DNA-binding targets, however, only constrained the evolution of the DNA-binding domains (Pearson *r* = −0.271, *P*-value = 0.045; [fig. 3D](#evw228-F3){ref-type="fig"}), as no significant correlation was seen with the evolutionary rates of domains involved in PPI (Pearson *r* = 0.081, *P*-value = 0.607; [fig. 3C](#evw228-F3){ref-type="fig"}). These findings demonstrate that the specific pattern of constraint differs by domain function(s). [Fig]{.smallcaps}. 3.---Pleiotropic constraint over functional domain evolutionary rate. X-axes represent the log transformed number of either DNA binding targets or TF--TF interactions and the Y axes are the log transformed evolutionary rates of functional domains, either protein-- PID or DNA-binding Domain (DBD) as measured by dN/dS. *(A)* The ln(evolutionary rate of the PID) plotted against the ln(TF--TF interactions), *n* = 651. *(B)* The ln(evolutionary rate of the DBD) plotted against the ln(TF--TF), *n* = 422. *(C)* The ln(evolutionary rate of the PID) plotted against the ln(DNA-binding targets), *n* = 44. *(D)* The ln(evolutionary rate of the DBD) plotted against the ln(DNA-binding targets), *n* = 55. dN/dS, evolutionary rate; TF--TF, no. of TF--TF interactions; PID, protein-interacting domains; DBD, DNA-binding domains; DNA-binding targets, no. of TF--DNA interactions.

Number of Functional Domains Affects Gene Evolution
---------------------------------------------------

In addition to the number of binding partners (either PPI or protein-DNA) affecting gene evolution, the number of domains per TF positively correlated with the evolutionary rates of the TFs. We investigated how the number of PPI domains correlated to the evolutionary rates of these domains, as well as, to the number of TF--TF interactions. We found that as the number of PPI domains increased the evolutionary rates of the PPI domains also increased (Spearman *r* = 0.167, *P*-value = 1e-08; [fig. 4A](#evw228-F4){ref-type="fig"}; [table 1](#evw228-T1){ref-type="table"}). This is consistent with a reduced constraint on domain evolution, as increasing numbers of PPI domains in a gene results in faster evolutionary rates. [Fig]{.smallcaps}. 4.---Pleiotropic constraint over functional domain count. X-axes for A--B show the number of PID identified within each TF. *(A)* The ln(evolutionary rate of the PID) plotted against the number of PID, *n* = 789. *(B)* The ln(TF--TF) plotted against the number of PID, *n* = 769. dN/dS, evolutionary rate; TF--TF, no. of TF--TF interactions; PID, protein-interacting domains; DBD, DNA-binding domains,. Table 1Summary statistics from linear models between the values described in column 1 and either the no. of PID of the no. of DBD for each proteinNo. of PIDNo. of DBDNo.Spearman *rP*-valueNo.Spearman *rP*-value**ln(dN/dS of PIDs)**7880.2011.318E-08220−0.1170.0834**Variance of ln(dN/dS of PIDs)**16−0.7771.07E-045−0.5840.335**ln(no. of TF--TF interactions)**768−0.5081.39E-51683−0.0300.434**ln(no. of TF--TF interactions per PID)**768−0.7792.44E-157223−0.0520.805**Variance of ln(no. of TF-TF interactions)**15−0.5920.0166−0.3650.42**ln(dN/dS pf DBDs)**1350.0550.524444−0.0360.448**Variance of ln(dN/dS of DBDs)**8−0.1440.7346−0.3120.4959**ln(no. of DNA-binding targets)**57−0.0210.9886−0.0840.439**ln(no. of DNA-binding targets per DBD)**33−0.1100.53786−0.2340.029**Variance of ln(no. of DNA binding targets)**50.1570.76640.8880.112[^3]

Increasing numbers of PPI domains correlated with both fewer TF--TF interactions overall and per domain. The correlation between the number of PPI domains and the number of TF--TF interactions was highly significant and negative (Spearman *r* = −0.455, *P*-value = 1e-51; [fig. 1B](#evw228-F1){ref-type="fig"}; [table 1](#evw228-T1){ref-type="table"}). Additionally, the number of PPI domains negatively correlated with the number of TF--TF interactions per PPI domain (Pearson *r* = −0.779, *P*-value = 2e-157; [table 1](#evw228-T1){ref-type="table"}; [supplementary fig. S1*a*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1) online). Therefore, overall more PPI domains correlated with fewer interactions per protein.

As the number of PIDs increased, the variance in the evolutionary rates of the PIDs decreased (Pearson *r* = −0.777, *P*-value = 0.0002; [table 1](#evw228-T1){ref-type="table"}; [supplementary fig. S1*b*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1) online). Additionally, as the number of PPI domains increased, the variance in the number of the TF--TF interactions also decreased (Pearson *r* = −0.592, *P*-value = 0.016; [table 1](#evw228-T1){ref-type="table"}; [supplementary fig. S1*c*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1) online). This relationship between the number of domains and both the domain evolutionary rates and number of TF--TF interactions was only observed for the PPI domains, as no significant correlations were found between the number of DNA binding domains and evolutionary rates of these domains nor with the number of DNA binding targets ([table 1](#evw228-T1){ref-type="table"}; [supplemantary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw228/-/DC1) online).

Pleiotropic Constraint in Disease Associating TFs
-------------------------------------------------

Finally, we tested whether mutations that predispose individuals to disease are more pleiotropic than those that do not, as such highly pleiotropic genes are more likely to have undergone selection. Such selection should constrain the evolutionary rates of more pleiotropic genes ([@evw228-B4]; [@evw228-B5]). We then compared the levels of pleiotropy between GWAS associated and non-GWAS associated TFs. TFs associated with human disease in a GWAS had significantly higher ln(no. of TF-TF interactions) than those not found in the GWAS catalog (GWAS associated genes (mean = 4.1), non-GWAS associated genes (mean = 3.5), *P*-value = 9e-14; [fig. 5A](#evw228-F5){ref-type="fig"}). A similar trend was observed for the ln(no. of DNA binding targets); however, this did not reach statistical significant (GWAS associated genes (mean = 10), non-GWAS associated genes (mean = 9.5), *P*-value = 0.078; [fig. 5B](#evw228-F5){ref-type="fig"}). The lack of statistical significance may be due to a greatly reduced sample size (*n* = 28). Additionally, GWAS-associated TFs are more evolutionarily constrained, as they appear to have lower ln(dN/dS) (GWAS associated genes (mean = −2.4), non-GWAS associated genes (mean = −2.1), *P*-value = 4e-6; [fig. 5C](#evw228-F5){ref-type="fig"}). These results indicate that highly pleiotropic genes are more likely to be associated with a disease phenotype when mutated, and disease associations are reflective of evolutionary rates. [Fig]{.smallcaps}. 5.---GWAS association with Pleiotropic functions. The X-axis of A--C splits the genes into two groups, genes that have been identified in at least one GWAS study and genes that have not (NO_GWAS). *(A)* The Y axis represents the log transformed number of TF--TF interactions, n of GWAS = 219, no of non-GWAS = 1,392. *(B)* The Y axis represents the log transformed DNA binding targets, no. of GWAS = 27, no. of non-GWAS = 134. *(C)* The Y axis represents the log transformed evolutionary rate of the full TF, no of GWAS = 223, no of non-GWAS = 1,708. Notches show 95% CI.

Discussion
==========

Pleiotropic Constraints on Evolutionary Rates of the Entire TF CDS
------------------------------------------------------------------

Our study provided supportive evidence that pleiotropy constraints the evolution of TFs, but importantly also demonstrated that the constraints operate in a domain specific manner. TF--TF interactions constrain the evolutionary rates of the entire TF-CDSs. This is consistent with previous studies of PPI networks ([@evw228-B16], [@evw228-B17]; [@evw228-B15]; [@evw228-B14]; [@evw228-B21]; [@evw228-B27]; [@evw228-B39]; [@evw228-B7]). However, unlike the prior studies we were also able to show that TF evolution was also constrained by the number of DNA binding targets. These data taken as a whole indicate that pleiotropic constraint is not limited to proteins with specific molecular functions but is a generic property of pleiotropy.

Constraints on Domain Specific Evolutionary Rates
-------------------------------------------------

We were also able to assess whether and the degree to which constraints operated within and across domains. TF--TF interactions not only constrained the entire gene CDS, as noted earlier, but the PPI domains also were significantly associated with constraint on the DNA-binding domains. In contrast, the constraint produced by the number of DNA-binding targets was restricted to the DNA binding domains, possibly explaining the overall weaker effect on the entire protein ([fig. 6A](#evw228-F6){ref-type="fig"}). This reduced correlation could also result from the fact that many of the DNA motifs that a TF binds *in vitro* are not functional and hence would not affect the evolutionary rate of the protein. This is easy to argue as 60% of DNA-binding targets were not upstream of transcription start sites and therefore are less likely to constrain evolution ([@evw228-B18]). Such noise in the data could lead to lower correlations between evolutionary rates and number of DNA-binding targets. However, if our lack of knowledge hides truly functional sites the degree of noise would be less. [Fig]{.smallcaps}. 6.---Possible molecular models of constraints. *(A)* Differential constrains applied to gene evolution from both the no. of TF--TF interactions and the no. of DNA binding targets. Blue line represents a linear diagram of a hypothetical protein containing 1 protein-interacting domain (Orange) and 1 DNA-binding domains (Red). *(B)* Ribbon diagram of a protein illustrating the effect of having a single protein-interacting domain (Left), versus multiple protein-interacting domains (right). Arrow shows direction of the global constraint.

Number of Domains Affect the Degree of Constraint
-------------------------------------------------

TFs with more PPI domains evolve at faster rates than those with fewer PPI domains, consistent with a reduced constraint on individual domains within each TF. This reduction in constraint can be explained by the finding that TFs with more PPI domains also tend to have fewer interactions per domain and per protein. Therefore, as each domain interacts with fewer proteins, there would be less constraint on each domain's evolution. This would result in faster evolution. However, these findings conflict with the prior literature, where it was shown that there was no significant correlation between the number PPI domains and average number of interactions in the human PPI network. Instead the correlations were driven by the proportion of each gene that encoded PPI domains ([@evw228-B55]). Additionally, in yeast it was shown that the more interacting surfaces that a protein has, the lower its evolutionary rate ([@evw228-B27]). While these studies do conflict with our results, it is important to distinguish these studies from our own, as they were not specifically looking at TFs. This distinction is important because of the overabundance of highly specific interactions and protein complexes found in the TF network ([@evw228-B45]). It is therefore important to note that these findings (regarding the number of PPI domains) may not be reflective of other classes of genes outside of TFs; this possibility will require further analyses.

At first glance, the negative correlation between the number of PPI domains and the number of TF-TF interactions is counter-intuitive. However, this can be explained by the hypothesis that TFs have evolved greater numbers of PPI domains, to allow for higher specificity of domain interactions ([fig. 6B](#evw228-F6){ref-type="fig"}). Consistent with this, it has been proposed that to increase the precision of gene regulation, protein interacting surfaces (mainly PPI domains) need to eliminate competition between prospective interacting partners; this can be accomplished by evolving domains specific to only a few interactions ([@evw228-B27]; [@evw228-B25]; [@evw228-B45]). This may occur for one of several varieties of reasons; for example, if a TF is part of a larger complex of proteins you might expect it to possess multiple PPI domains, with each domain being designated to a specific interaction with another member of the complex. This would allow the components to tightly regulate each complex's assembly, stability, and function.

Robustness and Evolvability in TFs
----------------------------------

Our results showed structural and functional elements of TF that significantly associate with their evolutionary rates. Our discussion has been largely focused on constraint, but such patterns amy also have implications for robustness and evolvability of genes. In a simplified view these three terms can be thought of as a spectrum; 1) constraint: the inability to tolerate mutation, 2) robustness: the ability to tolerate mutation without affecting function, and 3) evolvability: the ability to benefit from mutation ([@evw228-B30]) (resulting in negative, neutral, and positive selection, respectively). The largest implications derive from the correlations between the number of TF--TF interactions, the number of PID, and evolutionary rates. As argued earlier, TFs with many PIDs appear to have a higher specificity of interactions. The finding that these TFs evolve at faster rates also suggests that they are more robust, as mutations are less apt to disrupt their function(s) as a TF. Furthermore these mutations may allow the TF more likely to evolve novel interactions.

Correlation of the TF--TF and DNA-Binding Targets
-------------------------------------------------

We found a positive correlation between the number of TF--TF interactions and the number of DNA binding targets. It makes intuitive sense that these numbers are related to one another and suggests that there may be a causal relationship between them. This relationship could be due to either of the following two hypotheses:

1\) As a TF acquires more TF--TF interactions over the course of evolution, these novel interactions facilitate a given TF's binding to more sites in the genome;

2\) As a TF acquires more DNA binding targets over the course of evolution, these novel binding sites can place the TF in physical proximity to other TFs, facilitating more and novel TF--TF interactions.

Although speculative, we argue that the differential constraint on domain evolutionary rates between the TF--TF interactions and DNA-binding targets, shown in [figure 3](#evw228-F3){ref-type="fig"}, indirectly supports hypothesis 1. The reason for this is that if the DNA binding targets are dependent on the TF--TF interactions, it is likely that the evolutionary rates of the DNA-binding domains would be correlated to the number of TF--TF interactions ([fig. *3C*](#evw228-F3){ref-type="fig"}). However, if the alternative were true, then we would expect to find that the number of DNA binding targets would significantly correlate with the evolutionary rates of the PPI domains; since this was not observed this argues against alternative 2. It is also possible that this differential constraint could be the result of an unknown cofounder. Additionally, a similar model to hypothesis 1 has been put forth. In this model, as a transcriptional regulator (bound to DNA) interacts with new protein partners, the neighboring DNA sequences can then undergo selection to optimize the recruitment and affinity of the new protein interacting partner to the DNA sites ([@evw228-B46]). This model illustrates how the gain of novel TF-TF interactions can facilitate new DNA binding targets ([@evw228-B46]). This model also provides a more parsimonious means for evolving transcriptional circuitry, than hypothesis 2, due to the need for compensatory evolution. In hypothesis 1 this compensatory evolution would occur by mutating the neighboring DNA sequences; however, under hypothesis 2 the compensatory evolution would involve mutating the CDS in order to optimize the new TF--TF interactions. Because DNA is more robust than proteins, mutating DNA is likely to have less detrimental effects than mutating proteins. Furthermore, evolving new DNA binding targets would likely only facilitate a small number of novel TF--TF interactions, whereas new TF--TF interactions could potentially facilitate many DNA binding targets (one for each location where the new TF interacting partner is located on the genome).

Pleiotropy and Epistasis
------------------------

The correlation between the number of TF--TF interactions and the number of DNA binding targets also raises an interesting question regarding the likely connection between pleiotropy and epistasis. At the molecular level, pleiotropy is defined as the ability a gene product to be involved in multiple molecular functions, and epistasis can be defined as the ability of one gene to modulate the function of another gene. Over evolutionary time newly acquired molecular functions (i.e., pleiotropy) are capable of altering the function of another gene (i.e., epistasis), the altered gene function can, in turn, facilitate the acquisition of additional novel functions (i.e. pleiotropy). A similar non-evolutionary argument has bene made for the relationship of epistasis and pleiotropy ([@evw228-B47]).

Pleiotropic Constraint on Disease Genes
---------------------------------------

We showed that highly pleiotropic genes are more likely to be associated with a disease phenotype. This may be explained by two ideas: 1) The more processes a gene is involved in the more likely that gene is to be involved in an essential process, the disruption of which would result in a disease phenotype or 2) Disease phenotypes may arise from the disruption of multiple molecular processes, such as the disruption of cell cycle signaling pathways and apoptotic pathways in cancer progression ([@evw228-B49]; [@evw228-B20]). These alternatives are not necessarily mutually exclusive. We also showed that disease associated genes have a high probability of being evolutionarily constrained, as they appear to present with significantly lower evolutionary rates than non-disease associated genes. This indicates that disease status does appear to reflect purifying selection, as the lower evolutionary rate is consistent with some alleles being removed from a population over evolutionary time ([@evw228-B4]; [@evw228-B5]). When both the pleiotropic and evolutionary data are taken together these findings show that this pleiotropic constraint does not only exist at the molecular level, but is also applicable at the phenotypic level (i.e., clinical phenotypes) ([@evw228-B40]; [@evw228-B50]).

Limitations of This Study
-------------------------

There has been discussion as to how the bias of gene expression can influence the number of PPI that are known for a given protein. This is primarily driven by the fact that it is easier to identify interacting partners for highly expressed genes due to technological limitations. Several models have been put forth arguing that gene expression alone could affect evolutionary rates, regardless of pleiotropy. And while there is evidence to suggest that gene expression alone may constrain gene evolution, there have still been several studies that still show a significant (albeit weaker) correlation between the functional importance of a gene and evolutionary rates when controlled for gene expression ([@evw228-B51]; [@evw228-B60]). Unfortunately, there are several problems with interpreting these results in human gene evolution that are absent in model systems such as yeast, where much of this work has been done. Gene expression for complex animals are highly context dependent and the profiles will vary based on numerous factors, including which tissue the samples were taken from, race/ethnicity, age of the donor, and disease that the donor suffered from (such as from tumor cell lines). Therefore, adjustments for gene expression in human will likely change results and interpretation with respect to constraint and pleiotropy as a function of these and other factors. Nonetheless, we would argue that given the strength of some of the associations we detected the results for pleiotropy are likely to remain in at least some of the cases we observed.

Another limitation we encountered is how few TFs had DNA binding target data available. Due to the limited number of TFs with the available data, we found several correlations that were marginally significant or only near significant. With a small sample size it is difficult to say whether these correlations are real or not. Additionally, although not as big a problem, the PPI, domain descriptions and GWAS datasets are also incomplete, as not all interactions, domains, and disease associations are known for all TFs. With growing databases, the ability to assess the role of pleiotropy on gene evolution will improve and these relationships will continue to be resolved.

Conclusion
==========

In this study, we showed that molecular pleiotropy is not only capable of constraining gene evolution, but that this constraint appears to differ by molecular function. We also showed that the number of PPI domains appears to uniquely constraint TFs, as the correlations we found were not observed for other sets of proteins in prior studies. These findings have implications for studies of protein and network evolution. In addition, TFs that are more pleiotropic are more likely to be associated with human disease risk. These findings emphasize the importance of studying pleiotropy to better understand how patterns of genetic variation are shaped and how pleiotropy can contribute to human diseases.
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